PUT - SPRINTER OPEN END - DEXCOM Stock

DE000VD639H1

Market Closed - Boerse Frankfurt Warrants 13:46:12 2024-07-03 EDT
1.31 ^EUR	+7.38%

Current month	+21.30%
1 month	+50.57%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DEXCOM, INC.

Latest news about DEXCOM, INC.

Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time	06-28	AQ
Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.	06-27	BU
Wall Street: up, on the edge, despite rates	06-26	CF
Out with AI, in with defensive stocks	06-25

More news

Quotes 5-day view

Date	Price	Change
24-07-03	1.31	+7.38%
24-07-02	1.22	-2.40%
24-07-01	1.25	+15.74%
24-06-28	1.08	+10.20%
24-06-27	0.98	-11.71%

Real-time Boerse Frankfurt Warrants

Last update July 03, 2024 at 01:46 pm

More quotes

Static data

Product type	Knock-Out without Stop Loss
Buy / Sell	PUT
Underlying	DEXCOM, INC.
Issuer	Vontobel
WKN	VD639H
ISIN	DE000VD639H1
Date issued	2024-05-31
Strike	124.7 $
Maturity	Unlimited
Parity	10 : 1
Emission price	0.63 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	1.37 €
Lowest since issue	0.51 €

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.

Sector

More about the company

Ratings for DexCom, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DexCom, Inc.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

110.9 USD

Average target price

150.3 USD

Spread / Average Target

+35.55%

Consensus